M. Gleeson

发表

Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate‐severe flares: a phase 2A pilot multi‐center, randomized, double‐blind, sham‐controlled trial

John T. Chang, C. Siegel, J. Buckey, 2018, The American Journal of Gastroenterology.

Affinity of antigen encounter and other early B-cell signals determine B-cell fate.

L. Erickson, R. Noelle, M. Benson, 2007, Current opinion in immunology.

Quelling Inflammation with Ketosis and Steric Chemistry

R. Dickson, M. Gleeson, 2016, Clinical and Translational Gastroenterology.

Mast cells are essential intermediaries in regulatory T-cell tolerance

David C. Gondek, T. Strom, X. Zheng, 2006, Nature.

Systematic review: the safety and efficacy of hyperbaric oxygen therapy for inflammatory bowel disease

C. Siegel, J. Buckey, P. Dulai, 2014, Alimentary pharmacology & therapeutics.

The microbiota regulates susceptibility to Fas-mediated acute hepatic injury

M. Sogin, H. Morrison, G. O’Toole, 2014, Laboratory Investigation.

The rise and fall of long‐lived humoral immunity: terminal differentiation of plasma cells in health and disease

L. Erickson, R. Noelle, B. O’Connor, 2003, Immunological reviews.

Albumin Gains Immune Boosting Credibility

R. Dickson, M. Gleeson, 2015, Clinical and Translational Gastroenterology.

Interplay of Liver Disease and Gut Microbiota in the Development of Colorectal Neoplasia

M. Gleeson, 2019, Current Treatment Options in Gastroenterology.

Hyperbaric Oxygen Therapy is Safe and Effective for Hospitalized Ulcerative Colitis Patients Suffering from Moderate-Severe Flares: A Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial

John T. Chang, C. Siegel, J. Buckey, 2017 .